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To the Editor: Rickettsia conorii, 
the etiologic agent of Mediterrenean 
spotted fever (MSF), is transmitted 
to humans by the brown dog tick 
(Rhipicephalus sanguineus). MSF is 
endemic to Italy; incidence is highest 
in the south and on the islands of 
Sardinia and Sicily (1). Recently, the 
use of molecular methods has enabled 
identifi cation of other rickettsiae of 
the spotted fever group (SFG) from 
Ixodes ricinus ticks in northeastern 
Italy and in other areas of Europe (2–
6). R. monacensis was identifi ed as an 
etiologic agent of MSF-like illness in 
Spain (7).
We report a case of MSF-like 
illness in a 28-year-old man from 
Sassari in northwestern Sardinia 
who was admitted to the Infectious 
Disease Unit of the University of 
Sassari Hospital in April 2011. At 
admission, he reported fever (38.2°C) 
and headache of 2 days’ duration. 
At physical examination, he had a 
crusty skin lesion surrounded by 
edema and erythema, which was 
compatible with inoculation eschar, 
on the left calf. He had no rash. 
Laboratory results showed a slight 
leukocyte increase, hypocromic and 
microcytic anemia (hemoglobin 10.6 
g/dL [reference range 13.1–17.1 g/
dL], mean corpuscular volume 67.7 
fL [reference range 81–88 fL], mean 
corpuscular hemoglobin concentration 
29.6 g/dL [reference range 33–35 
g/dL]), hyperbilirubinemia (total 
bilirubin 1.36 mg/dL [reference range 
0.2–1.3 mg/dL], direct bilirubin 0.49 
mg/dL [reference range 0.0–0.6 mg/
dL]), and erythrocyte sedimentation 
rate 37 mm/h (reference range 0–25 
mm/h). The remaining parameters 
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were within reference ranges. A small 
skin sample taken from the inoculation 
eschar and whole blood were stored 
at –30°C. The patient immediately 
started taking doxycycline 100 mg 
every 12 hours. Serologic tests 
were negative for R. conorii IgM 
and IgG (ELISA) and positive for 
SFG Rickettsia spp. IgG on indirect 
immunofl uorescence with a titer of 
128. After 24 hours of antimicrobial 
drug therapy, he was afebrile; he was 
discharged on day 3. He completed a 
7-day course of doxycycline at home 
and recovered completely.
The skin biopsy sample, collected 
in phosphate-buffered saline, and 
whole blood were obtained before 
antimicrobial therapy began and 
were subjected to DNA extraction. 
Bacterial detection and identifi cation 
were conducted by using molecular 
methods based on real-time PCR, 
classical PCR, and nucleotide 
sequencing (Table).
A set of primers for gltA gene 
that encodes the citrate synthase 
enzyme (8) was used to determine that 
the organism belonged to the genus 
Rickettsia, which includes the SFG 
and typhus group. Each real-time PCR 
reaction was performed by QuantiTect 
SYBR Green PCR kit (QIAGEN, 
Hilden, Germany) by using 20 ng of 
purifi ed DNA. R. conorii and R. typhii 
were used as positive controls for SFG 
and typhus group, and Anaplasma 
phagocytophilum, Bartonella hense-
lae, Ehrlichia chaffeensis, and 
Coxiella burnetii (Bartonellaceae 
and Coxiellaceae members) served 
as negative controls. Results were 
checked for the specifi c molecular 
length by electrophoresis on a 3% (wt/
vol) agarose gel.
The skin biopsy specimen of the 
inoculation eschar was positive for 
Rickettsia spp. The whole blood sample 
was negative for Rickettsia spp.
These results were confi rmed 
by amplifi cation of the ompA gene 
by using the ompA–F and ompA–R 
primers (9) and by the sequencing of 
the PCR amplicon. The nucleotide 
sequence analyzed by using the 
BLAST search tool (www.ncbi.n/m.
nib.gov/blast) showed 100% identity 
with the R. monacensis isolate N72 
(GenBank accession no. FJ919650.1). 
We identifi ed R. monacensis as cause 
of MSF-like illness in the patient 
reported here.
Our results have several clinical 
and microbiological implications. 
Although MSF-like illness is highly 
endemic to Sardinia, to our knowledge 
no pathogens other than R. conorii had 
ever been identifi ed. Antibodies against 
R. monacensis were not detected by 
the R. conorii ELISA commonly used 
in hospital laboratories. In contrast, 
indirect immunofl uorescence, which 
cannot distinguish between rickettsial 
species because of cross-reactivity, was 
positive. Therefore, the cocirculation 
of R. monacensis and, possibly, of 
other SFG rickettsiae, could lead to 
misdiagnosis and therapeutic delay. 
Furthermore, in consideration of the 
negative result in whole blood, a small 
skin sample from the eschar might 
improve the diagnostic sensitivity of 
PCR.
We did not perform entomologic 
studies. However, I. ricinus ticks, 
which are considered vectors of R. 
monacensis, are widely distributed 
in Italy and have been found in 
Sardinia, although less often than 
other tick species (10). Moreover, it 
is not excluded that other ticks might 
act as vectors for R. monacensis in 
Sardinia, where ticks of the genus 
Rhipicephalus are prominent. Mole-
cular investigations of ticks could 
better clarify the extent of circulation 
of SFG rickettsiae in Sardinia.
Identifi cation of R. monacensis 
as a cause of MSF-like illness in 
Sardinia expands the list of pathogenic 
rickettsiae circulating in Italy. It 
also highlights the need for further 
investigation in humans and vectors 
to understand infection dynamics and 
improve diagnosis and treatment of this 
potentially life-threatening disease.
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Table. Selected inner primers used to amplify rickettsial gltA and ompA genes* 
Rickettsial groups Gene Primer Nucleotide sequence, 5   3 Product size, bp Reference
Rickettsiae spotted fever 
group plus typhus group
gtlA gltA–F TCGCAAATGTTCACGGTACTTT 74 (8) 
gltA–R TCGTGCATTTCTTTCCATTGTG   
Rickettsiae ompA ompA ompA–F ATGGCGAATATTTCTCCAAAA 632 (9) 
  ompA–R GTTCCGTTAATGGCAGCATCT   
*gltA, citrate synthase; ompA, outer membrane protein A. 
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To the Editor: During 2000–
2010, serial Leishmania isolates 
obtained from an HIV-infected patient 
who was not responding to treatment 
showed a gradual decrease in in 
vitro miltefosine susceptibility. We 
performed L. donovani miltefosine 
transporter (Ldmt) gene analysis 
to identify an association between 
miltefosine resistance of reference 
L. donovani lines and variability in 
miltefosine response of L. infantum 
isolates. A new single-nucleotide 
polymorphism (SNP), L832F, was 
identifi ed, which might be a marker of 
miltefosine resistance in leishmaniasis.
The patient, a 46-year-old 
woman, had lived in France since 
1994 but regularly returned to Algeria, 
her country of birth. HIV-1 infection 
was diagnosed in 1991. Antiretroviral 
therapy was initiated in 1993, leading 
to undetectable viral load and a 
CD4+ T-cell count of 185 cells/mm3 
(reference >450/mm3). Concurrent 
conditions were thoracic herpes 
zoster in 1996, hairy leukoplakia of 
tongue, oropharyngeal candidiasis, 
and chronic renal failure of unknown 
cause since 2000.
Visceral leishmaniasis was 
diagnosed in 1998 by culture of a 
bone marrow smear, which showed 
intracellular amastigotes. Use of 
meglumine antimonate (Glucantime; 
Sanofi , Paris, France), a drug of choice 
for the treatment of leishmaniasis, 
was contraindicated because of 
pancreatitis in the patient and in 
vitro isolate susceptibility variation; 
therefore, induction therapy consisted 
of liposomal amphotericin B (AmpB 
[AmBisome; Astellas Pharma US, 
Deerfi eld, IL, USA]) at a dose of 3 mg/
kg/d for 5 consecutive days, then 1× 
week for 5 weeks (total dose 30 mg/
kg) during 1998–2000 (Table). The 
same medication was administered for 
relapses at 4 mg/kg/d for 5 days, then 
4 mg/kg 1× week for 5 weeks (total 
dose 40 mg/kg) during 2001–2010. 
Given the adverse effects of AmpB 
and the availability of oral miltefosine 
(Impavido; AEterna Zentaris Inc., 
Quebec City, Quebec, Canada), the 
latter drug was used for maintenance 
treatment during 2001–2007 at 50 mg 
2×/d. Leishmaniasis was monitored 
by leukocytoconcentration and culture 
of blood samples on Novy-Nicolle-
McNeal medium.
When signs of biological and 
clinical relapse appeared, bone 
marrow was aspirated for parasite 
detection. After culture of the aspirate 
and isoenzyme determination, the 
strain was identifi ed as L. infantum, 
zymodeme MON-24. Eleven relapses 
were documented; all were confi rmed 
by positive direct examination of bone 
marrow or blood, but cultures of only 
7 samples yielded positive results 
(Table).
The susceptibility of 4 
cryopreserved isolates (S1, S3, 
S4, and S6; Table) to AmpB and 
to miltefosine was studied in the 
in vitro promastigote and axenic 
amastigote form by determining the 
concentrations inhibiting parasite 
growth by 50% (1,2). The 50% 
inhibitory concentration (IC50) 
was determined in parallel for the 
following reference L. donovani 
lines: a wild-type L. donovani LV9 
(MHOM/ET/67/HU3) line (LV9 
WT), a wild-type L. donovani DD8 
(MHOM/IN/80/DD8) line (DD8 WT), 
a laboratory miltefosine-resistant 
line obtained from LV9 WT (LV9 
miltefosine-R, resistant to 90 μmol/L 
miltefosine), and the laboratory AmB-
resistant line obtained from DD8 WT 
(DD8 AmB-R, resistant to 1.4 μmol/L 
AmB) on promastigote and axenic 
amastigote forms (3,4).
The AmB susceptibility of the 
isolates did not change notably over 
time; IC50 values ranged from 0.09 
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